2-amino-6-propyl-4H,5H,6H,7H-thieno[2,3-c]pyridine-3-carboxamide, 95.0%, 2.5g

2-Phenyl-2-(pyridin-2-yl)acetamide, 95.0%, 500g

tert-Butyl 1-amino-3-azabicyclo[3.2.0]heptane-3-carboxylate, 97%, 250mg

GC-Kapillarsäule ROTI®Cap-1, unpolar, L 50 m, Ø-Innen 0,32 mm, Filmd. 3,00 µm, 1 Stück

TERT-BUTYL 3-(6-CHLORO-2-(METHYLTHIO)PYRIMIDIN-4-YL)AZETIDINE-1-CARBOXYLATE, 95.0%, 500mg

2-(Piperidin-4-yl)phenol, 95.0%, 5g

(S)-ethyl 2-amino-4-fluoro-4-methylpentanoate (R)-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylate, 98%, 1g

2-Iodo-3-(trifluoromethyl)benzoic acid, 95.0%, 10g

Tetracosanedioic acid, 98%, 5g

1-Methyl-5-nitro-1H-pyrrolo[2,3-b]pyridine, 97.0%, 25g

(R)-a-Allylproline�HCl, 98.0%, 1g

6-(2-thienyl)-2-thioxo-2,3-dihydropyrimidin-4(1{H})-one, 95.0%, 500mg

Methyl 5-bromo-2-chloro-3-methoxybenzoate, 98.0%, 1g